Product Information
PRIMAQUINE 26.3 MG TABLET is a generic product labeled by Sanofi-Aventis U.S. LLC, priced at $1.9639 per EA under NDC 00024159601. Its NADAC has been published 91 times since Aug 21, 2024.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
15 mg/1
Manufacturer
Sanofi-Aventis U.S. LLCNDC
00024159601
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
5/21/2025
Active Ingredients
PRIMAQUINE PHOSPHATEApproval Type
New Drug (NDA)
FDA Application
NDA008316FDA Approved
Before 1982
TE Code
AB
On Market Since
4/15/2011
Pharmacological Classes
Price Statistics
The NADAC for PRIMAQUINE 26.3 MG TABLET has been published 91 times since Aug 21, 2024, and over the history we have for it it has risen 17.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.9639 per EA |
|---|---|
| All-time high | $1.9639 (May 13, 2026) |
| All-time low | $1.6638 (Oct 23, 2024) |
| 52-week high | $1.9639 |
| 52-week low | $1.9639 |
| Median price | $1.9639 |
| Average price | $1.8736 |
| Largest weekly change | +14.6% (Mar 19, 2025) |
| Weeks tracked | 91 |
| Tracking since | Aug 21, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
0.0%
1Y
0.0%
3Y
N/A
5Y
N/A
All
+17.9%
Last surveyed May 13, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PRIMAQUINE 26.3 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PRIMAQUINE 26.3 MG TABLET, manufactured by Sanofi-Aventis U.S. LLC, is $1.9639 per EA (NDC 00024159601), effective May 13, 2026.
How has the price of PRIMAQUINE 26.3 MG TABLET changed over time?
Over the history we have for it, the NADAC for PRIMAQUINE 26.3 MG TABLET has risen 17.9%. It has been tracked across 91 weekly CMS publications since Aug 21, 2024.
What are the highest and lowest recorded NADAC prices for PRIMAQUINE 26.3 MG TABLET?
Since Aug 21, 2024, the NADAC for PRIMAQUINE 26.3 MG TABLET has ranged from a low of $1.6638 (Oct 23, 2024) to a high of $1.9639 (May 13, 2026), with a median of $1.9639 per EA.
Are there cheaper alternatives to PRIMAQUINE 26.3 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as PRIMAQUINE 26.3 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PRIMAQUINE 26.3 MG TABLET?
PRIMAQUINE 26.3 MG TABLET (NDC 00024159601) is labeled by Sanofi-Aventis U.S. LLC, and CMS classifies it as a generic product.